Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy. - Wikidata - wikimedia - TriplyDB

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

http://www.wikidata.org/entity/Q37641455

about

RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.Nanoparticle/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs?Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation.Advanced nanomaterials targeting hypoxia to enhance radiotherapy Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy

P2860

Q45871459-DC5E4178-AE68-4C0E-8BBD-C26BD8752FEC Q47937284-CF603C45-E37A-48B6-80D1-9817E8358E7F Q48190879-FB61E599-07C3-4987-AE68-4AB3CB0AB1BD Q57487097-AF9C4FC6-FB38-4A3E-AEFA-EAC266688472 Q59138138-43956778-F312-48F3-AE7A-C06F4E9CB108

P2860

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

http://www.wikidata.org/entity/Q37641455

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

@en

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

@nl

type

label

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

@en

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

@nl

prefLabel

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

@en

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

@nl

P1433

Q37641455-4F1DB94B-5708-402F-A2CA-9FF9F4BE92CB

P1476

Q37641455-ED95E35F-E6DD-4DA4-AA6C-91A4FD0CBC01

P2093

Q37641455-116E90AE-A96E-4945-9F34-5C120F0C7E86

Q37641455-44F7E6F4-6E35-4172-A88F-1BFB05DD294B

Q37641455-5A53DCC6-5524-40AA-8E5E-ED5F2BC6F087

Q37641455-67114B74-5398-4AA2-B415-A4D4406158D7

Q37641455-95651355-68FE-4245-B993-C74832A14A91

Q37641455-BEB08119-1302-430B-B868-46972F67DF52

Q37641455-D9FDA533-D13A-4AC3-8067-DCDFAD537239

Q37641455-DFDA9012-4229-4B6B-A019-C4F424C552B4

Q37641455-E0942C6F-DFA9-4094-8390-9C654B17EB24

P2860

Q37641455-07630882-16B9-49FB-9076-7F39700E6FBC

Q37641455-0A3AB7F1-C11F-44EB-8EF0-BE39715BC587

Q37641455-0AA8D44F-B35A-459F-8E10-4166BD15EF4D

Q37641455-13A4C2B7-F202-4D83-9EA8-B456823851DC

Q37641455-1E7EC2F7-EBDC-4CEE-91B6-5A0C546045B4

Q37641455-203F06EE-36FB-4A15-8176-B2714FFBAF82

Q37641455-25E6870C-E36D-4DB0-B563-FF4C6EF0DC76

Q37641455-308EAFE6-2680-4320-B393-085DF42DD65C

Q37641455-34C5428A-98AA-4F7B-A767-A3E0573C8C51

Q37641455-37CEF7BC-26DB-4373-8647-4BEA12162FDB

P304

Q37641455-E7D6507D-0220-4078-9A35-D397D351EB5C

P31

Q37641455-B4BBB70F-82E8-4F11-B3AC-DB89669ADFC3

P356

Q37641455-20C02F25-8975-44BC-9C5F-24E3F28D2E42

P407

Q37641455-D2DA0E55-83BE-4998-82F2-4154770B872D

P478

Q37641455-4569ADAE-EA10-4258-9D32-32AB73C1AED8

P577

Q37641455-2CE4BF51-EB77-4675-A02B-E57F8020AF29

P698

Q37641455-C9B29ED7-4A37-4F88-9544-F81F45553EC2

P921

Q37641455-FC5333E6-931C-4626-A619-D0E65ADADF33

P932

Q37641455-DB19997F-9A53-4E46-A31E-E935E21D8C71

P356

P1433

International Journal of Nanomedicine

P1476

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.

@en

P2093

Bai-Yang Li

http://www.w3.org/2001/XMLSchema#string

Hong-Mei Liu

http://www.w3.org/2001/XMLSchema#string

Ling-Yu Zeng

http://www.w3.org/2001/XMLSchema#string

Ru-Tong Yu

http://www.w3.org/2001/XMLSchema#string

Wen Li

http://www.w3.org/2001/XMLSchema#string

Ya-Fei Zhang

http://www.w3.org/2001/XMLSchema#string

Yan-Dong Xie

http://www.w3.org/2001/XMLSchema#string

Yi-Fan Cai

http://www.w3.org/2001/XMLSchema#string

Yu-Ling Li

http://www.w3.org/2001/XMLSchema#string

P2860

Current prospects for RNA interference-based therapies

Exploiting tumour hypoxia in cancer treatment

Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes.

Hypoxia--a key regulatory factor in tumour growth

Targeting hypoxia in cancer therapy

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Hypoxia is important in the biology and aggression of human glial brain tumors.

Lipid-like materials for low-dose, in vivo gene silencing

Tertiary-amine functionalized polyplexes enhanced cellular uptake and prolonged gene expression.

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo

P304

1065-1083

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S125286

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28223799

http://www.w3.org/2001/XMLSchema#string

P921

P932

5308568

http://www.w3.org/2001/XMLSchema#string